Home > Openweb : Advisory Board
Who is Leading OPEN and Why?
The OPEN Advisory Board brings together leading pharmacists from hospital cancer programs around the nation.
The Advisory Board is chaired by Ernie Anderson, Jr., MS, RPh, Director of Lahey Clinic’s pharmacy. He is a strong advocate of greater education and a greater role for oncology pharmacists in the decision-making processes that affect their ability to provide a quality service.
“There has never been a greater need for an oncology pharmacist network,” said OPEN Chairman Ernie Anderson. “We are constantly facing new challenges in a very complex field, and within a year, perhaps more, we can expect a significant influx of new cancer patients. OPEN is the way that we can stay on top of this ever-changing arena, and indeed, there is a real possibility, working with ACCC, that we can affect those changes.”
OPEN Advisory Board
Steven L. D’Amato, RPh
Chair
Clinical Oncology Specialist, Maine Center for Cancer Medicine
Scarborough, Maine
Ernest R. Anderson, Jr. MS, RPh
Director of Pharmacy, Lahey Clinic
Burlington, Massachusetts
Susan Goodin, PharmD, BCOP
Director of Pharmacy, Cancer Institute of New Jersey
New Brunswick, New Jersey
Phil Johnson
H. Lee Moffitt Cancer Center
Tampa, Florida
Jim M. Koeller, MS
Professor, Pharmacotherapy Department
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Edward G. Szandzik, RPh, MBA
Director of Pharmacy, Henry Ford Health System
Detroit, Michigan
Anthony B. Szetela, PharmD, BCOP
Clinical Pharmacy Specialist, Good Samaritan Regional Medical Center
Phoenix, Arizona
Andrew Wilson, PharmD
Director, Pharmacy Services, Virginia Commonwealth University Health System
Richmond, Virginia
Brian Romig
Moses Cone Health System
Greensboro, North Carolina
